Category: Hamster fun and information

Why price is the last thing I look at

A message from our friends at The Trading Pub

While most traders watch price action…

Here’s what many miss… Price is the LAST thing to move.

What moves first is what I call “money flow”.

And when you can track every dollar flowing into and out of a particular asset in real time… you can spot reversals before they happen.

Take what happened on Tuesday, June 24th…

The SPY was drifting lower all afternoon… Most traders would have seen weakness and expected more downside.

But at exactly 1:25 PM, something interesting happened on my screen…

I could see 6.4 million bullish transactions flooding into the market – even though the SPY price hadn’t moved yet.

This created what I call “bullish divergence” – money flowing in while price stays flat.

It’s like watching institutional money quietly position themselves before the crowd catches on.

Anyone following the flow could have placed a simple trade at 1:25… and watched the SPY shoot up like a rocket over the next 18 minutes.

And according to our research, if they had placed a 0DTE option…

Well, the result would have been a 76% gain in 39 minutes.

While there would have been smaller gains and some that did not work out…

This signal happened in real time with a group of 578 traders who’ve been following this approach.

The reason most traders miss these moves is simple… They’re often looking at the wrong thing.

They watch price charts, RSI, moving averages… all lagging indicators that tell you what already happened.

But “money flow” tells you what’s ABOUT to happen.

When you can see capital pouring into the SPY before price reacts, you’re essentially front-running the market’s next move.

I’ve been quietly developing this approach for months, and the results from our research speak for themselves…

73.2% win rate across 116 trades… average hold time under 1 hour… average return of 16.4% per trade.

While I won’t be reckless in guaranteeing future returns or against losses…

If you want to see exactly how “money flow” works – and how to spot these SPY reversals before they rip – I’ve just put together a short presentation that goes over everything I’ve discovered.

You’ll see the complete breakdown of how to “follow the money” in real time and catch these opportunities 3-5 times per day.

Get your hands on the presentation here.

Today’s Featured Story

Stop Overlooking Qualcomm—Here’s What the Market’s Missing

Written by Sam Quirke

Key Points

Qualcomm has slid about 10% from its pre-earnings level despite solid results.
Revenue rose year-over-year, EPS topped analysis expectations, and guidance also came in hot.
The stock’s RSI is already nearing oversold levels, while sellers have failed to break last week’s low.

Shares of tech giant Qualcomm Inc. (NASDAQ: QCOM) are trading just under $148 after a sharp post-report slide, a bitter pill for investors who had been cheering a steady rally since April. That uptrend marked a welcome change from years of frustrating chop, so the swift sell-off feels painful.

Step back, though, and the story looks very different. Last week’s numbers were not only fine, but also the kind of update that normally pushes a stock higher.

Revenue landed in line with expectations and grew at a double-digit rate from a year ago. Earnings per share beat consensus on a non-GAAP basis, and more importantly, management’s outlook signaled confidence.

The high end of its revenue guidance came in above what the Street had penciled in, and the same was true for earnings. On the face of it, this was the combination investors typically want to see heading into the back half of the year, yet the stock finds itself down nearly 10% from its pre-earnings level.

Why the Market’s Reaction Looks Off

So why the sell-off?

A single narrative seems to have taken over, at least for now: anxiety that Apple Inc (NASDAQ: AAPL) will continue shifting modem development in-house, which could end a long-standing line of business for Qualcomm.

However, that risk is not new, and management addressed it directly in the report and reiterated that Qualcomm’s growth does not depend on a single customer. The company has been expanding and diversifying its revenue streams for some time, so this should remain a priority.

The valuation landscape favors the bullish side. Qualcomm remains one of the cheaper ways to own a leading semiconductor stock compared to the mega-tech cohort.

And the good news for those of us on the sidelines weighing up a position right now—this discount still exists even as the company’s execution continues to improve and management’s guidance points higher.

What the Chart Is Signaling Now

Technically, the uptrend from April has been broken, and shares are back to levels last seen in early spring. That matters. However, bearish momentum looks to be nearing exhaustion on the downside.

The stock’s relative strength index (RSI) is approaching extremely oversold territory, a zone that has marked turnaround points for Qualcomm in the past. Equally important is the fact that sellers have failed to send the price below its post-earnings low on two straight attempts, a sign that buyers are starting to step in in earnest.

Investors should watch the next few sessions to confirm this. If Qualcomm’s price stays above last week’s low, the chances increase that a new support level is forming. A decisive close back above the initial gap-down area would strengthen the case that the sell-off was a temporary shock, rather than the start of a full reversal.

The Analysts Remain Bullish

The bullish thesis is supported by the fact that even as investors rushed for the exit last week, Wall Street has not given up.

Qualcomm has enjoyed several bullish ratings and updates from analysts in recent weeks, including last week’s update from Sanford Bernstein, which also gave the stock a $185 price target. From where Qualcomm closed on Monday, that’s pointing to a targeted upside of some 30%, not to be sniffed at.

The consistent messaging in these updates matters; they all highlight a still-attractive valuation, an improving growth runway, and a revenue-diversification strategy that’s starting to pay dividends.

That does not guarantee a straight line higher, but it does suggest that the path of least resistance may still be up once the dust settles.

Thank you for subscribing to The Early Bird, MarketBeat’s 7:00 AM newsletter that covers stories that will impact the stock market each day.

This message is a paid sponsorship for The Trading Pub, a third-party advertiser of The Early Bird and MarketBeat.

The profits shown are not typical and you may lose money. Performance is not indicative of future results. Between April 14th and July 1st, 2025, 0DTE options were applied to 116 trade signals from the Roger Scott Trading Zone Live Telegram Channel. The win rate was 73.2%, with an average return of 16.4%—winners and losers included—and an average hold time of under 1 hour.

If you need help with your subscription, please contact MarketBeat’s U.S. based support team at contact@marketbeat.com.

If you no longer wish to receive email from The Early Bird, you can unsubscribe.

Featured Link: Your Bank Account Is No Longer Safe (From Priority Gold)

Hamster fun and information

I’m confused…

Hey there,

Over the past week, you have received several emails about MarketBeat All Access, but you didn’t sign up for the 30-day free trial.

I’ll be honest; I was surprised to see you haven’t accepted this offer. I am a little confused only because we had many people start the trial; I thought you’d be one of them. With this trial, customers have discovered and appreciated the unique advantage this service provides with its best-in-class portfolio monitoring tools and full access to MarketRank stock ratings.

So why didn’t you accept this offer?

I took some time to think about the possible hesitation from people like you, and suddenly, it all made sense.

Yes, it is completely free to get the 30 day trial subscription, and I don’t think anyone is complaining about that. However, I would assume the fear of getting credit card charges immediately after the trial ends stops so many customers in their tracks.

We’ve all had at least one free trial experience with an unscrupulous marketer behind it who has made it impossible to cancel in time. And then fight us tooth and nail on the refund. No one wants to deal with that.

We don’t either and that is not the way we do business!

Then again, how would you know we don’t take that approach? We haven’t met in person. We’re just a South Dakota-based media and research company that sends timely investment news and ideas to your inbox.

So, let’s address this head on to give you the reassurance you need to start your 30-day trial:

Renewal Reminder. 7 days before the end of the trial, we will send you a reminder email to cancel. Almost no one in the industry does this. We only want you to pay for a subscription if you actually find value in it.
30-Day Satisfaction Guarantee. You may cancel up to 30 days after the trial converts to a paid membership and get a full refund if you are unsatisfied for any reason. No questions asked. No commitment needed.

There is no risk in moving ahead with a 30-day trial of MarketBeat All Access.

Our team has spent years building best-in-class research tools and hiring the best editors to help you identify the best stock ideas for your portfolio. With your free subscription, you’ll get full access to our MarketRank ratings, top stock lists, portfolio monitoring tools, advanced research tools, and premium newsletters.

Our tools, reports, and newsletters provide you with the market commentary and financial data you need to stay on top of the market action.

We’ll show you which stocks Wall Street’s top analysts are fawning over and whether we think they’re right.

We’ll send you short-term trading alerts when we think there’s an obvious 5-day or 10-day trade to ride a wave of market news.

Best of all, our editors go the extra mile to explain the all-important “WHY” behind each trade. As in, why is the stock attractive and what is the upside potential?

If you want to discover the successful methods that my team of experts and I use to outperform the market, get started with a 30-day trial to MarketBeat All Access.

Over the next 30 days, you will get ongoing commentary and updated trades to find more ways to carve profits out of this challenging market environment.

After that, the choice is yours. Cancel if it doesn’t suit your needs. Or stay on board to enjoy years of investment success.

I have removed the risk so that you can enjoy the reward. Click below to get started!

Get your 30-day trial of MarketBeat All Access here

Talk soon,

William Bushee
Vice President, MarketBeat.com

Tuesday’s Featured Content

Why Bloom Energy Stock Could Break to New Highs

Written by Gabriel Osorio-Mazilli

Key Points

Bloom Energy stock has broken past previous highs recently, that doesn’t mean a new ceiling can be made, a bet some are already making.
With strong fundamentals, not all EPS growth has been fully priced into the stock yet.
Wall Street analysts and savvy investors see this name reaching for a new high shortly.

Buying a stock as it’s pushing toward or breaking through a 52-week high can feel daunting, since above that price lies uncharted territory. Yet that’s often exactly when you should double down on your initial thesis, because larger players tend to join the battle at these key breakout levels.

One company that’s been breaking out recently and giving investors plenty of reasons to expect further gains is Bloom Energy Corp. (NYSE: BE). Unlike many traditional energy firms, Bloom Energy focuses on renewable, clean-energy solutions.

With several upcoming catalysts on the horizon and oil prices widely anticipated to trend higher in the second half of 2025 amid ongoing geopolitical and economic uncertainty, renewables become an increasingly attractive alternative. That’s precisely where Bloom Energy stands to shine.

Giving Short Sellers a Run for Their Money

Over the past month alone, Bloom Energy stock has delivered a stratospheric rally of up to 60%. That momentum could only be the beginning, considering how much of the stock’s float is now held in short positions. Up to $1.14 billion worth of shorts are now open in the market, which investors need to keep front and center.

This matters because, as the stock continues its aggressive bull run, short sellers will eventually have to close their positions and cut their losses, which involves buying back the stock they borrowed to sell in the first place. This event, a massive exodus of shorts, is known as a short squeeze, as it creates additional buying pressure.

That additional buying pressure could be one of the main catalysts that bulls can enjoy for Bloom Energy stock in the coming months, assuming the company can stay on this current path. There’s an answer to that, too, for Bloom Energy, as stocks that break out of 52-week highs typically start to gain attention around Wall Street circles.

One of the latest members to express optimism for Bloom Energy shares is UBS Group analyst Manav Gupta. As of late July, he reiterated a Buy rating on the stock, coupled with a new $41 per share valuation. Even though this call implies an additional 8% upside from today’s prices, chances are other analysts will have to raise their targets soon.

Bullishness Spreads for Bloom Energy Stock

Other than Wall Street analysts feeling comfortable with new upgrades, another benefit of a stock breaking past its old 52-week high is that most long-only fund managers tend to systematically buy these stocks as part of their fundamental and momentum strategies.

Investors can see this at play with those from DekaBank Deutsche boosting their holdings in Bloom Energy stock by as much as 27.5% as of late July 2025, as well. In the latest vote of conviction, they now have a net position worth up to $14.7 million, pointing to higher prices in this company moving forward.

One word of caution for investors, though, is that the company is reporting its next quarterly earnings results on Thursday, July 31, in the after-market hours, meaning that the future growth potential could already be priced in after this massive rally. However, looking at some current market gauges can wash away some of these doubts.

The price-to-earnings growth ratio (PEG) is a useful metric investors can use to gauge whether today’s valuations are pricing in all future earnings. Any measure below one is considered not priced in yet, and Bloom Energy stock’s 0.7x PEG multiple suggests there is still plenty of upside left before earnings growth is fully priced in.

This could also explain why the broader market is now willing to pay a price-to-book (P/B) multiple of up to 15.1x for Bloom Energy stock. This is a massive premium above the energy sector’s average valuation of only 3.9x on a P/B basis.

While some investors may see this as overextended and expensive, seasoned participants will remind them that the market is always willing to pay up for the companies it expects will outperform the peer group and the broader indexes as well.

Judging by the momentum, the level of short interest, and institutional buying, Bloom Energy is one of those stocks that will prove the market correct by breaking into a new, higher level.

Thank you for subscribing to DividendStocks.com‘s daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news.

If you need help with your subscription, please don’t hesitate to email MarketBeat’s South Dakota based support team at contact@marketbeat.com.

If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.

Further Reading: “Fed Proof” Your Bank Account with THESE 4 Simple Steps (From Weiss Ratings)

Hamster fun and information

Robots Are the Next Big AI Play – These…

Eric Fry
Editor, Smart Money

DAILY ISSUE

Robots Are the Next Big AI Play – These Stocks Are Set to Soar

VIEW IN BROWSER

Tom Yeung here with today’s Smart Money.

In the 1962 pilot episode of The Jetsons, Jane Jetson, a space-age housewife, wants a robot maid.

The family can’t afford one, and so they end up at a U-Rent A Maid, where the salesman unloads his least desirable model on the Jetsons: Rosey the Robot.

Rosey was a surprise hit, quickly becoming a mainstay of the show.

The cheerful helper was a departure from the killer robots of the 1950s. Instead of world domination, Rosey was more focused on cooking and cleaning for her new family.

Yet, given the right hardware, the robots of the future will be capable of far more than household chores.

Thanks to AI, robots are now stepping off the screen and into the real world – and taking over physical tasks once reserved for humans.

This shift will reshape entire industries… and reward those who get in position early.

So, today, let’s take a look at how Rosey the Robot is quickly coming to life.

Then, I’ll share how you can access several recommendations set to capitalize on the growing world of robotics.

Let’s dive in…

Recommended Link

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast. Watch now…

The Fabric of the Robotics Revolution

Consider sewing machines, a device that 75 million people worldwide use for their livelihoods. That’s roughly 1% of the human population.

Three centuries of industrialization and we’re still producing garments by hand… but not for long.

Source

For decades, sewing has been considered too difficult for ordinary robotic arms to manage.

Fabric stretches and folds in unpredictable ways, and researchers in the 1980s and 1990s essentially gave up after realizing that assembly line-style robots with delicate “nippers” could not consistently make good stitches.

But AI is now changing that.

In March, a team of Chinese researchers used transfer learning (a form of AI) to train robots to “swing” fabrics to flatten them. It’s the way you might spread out a bedsheet.

Then, in April, a separate Chinese team used a convolutional neural network (another form of AI) to help robots visually recognize the quality of fabric seams, an essential step for robotic sewing.

These efforts have come so quickly that China has now launched a national R&D initiative to create a factory-ready robotic sewing machine by 2026.

Meanwhile, AI researchers are making shockingly rapid advancements in other areas. Last year, a group of researchers at the University of Tokyo even demonstrated a human robot that could drive a car around a corner. It took two minutes… but that’s far better than anything before.

And more improvements coming as, thanks to AI, robots’ “brains” catch up with their “brawn.” Advancements in chipmaking have finally made it possible to train and test humanoid robots at scale.

Then what?

Imagine buying a modern-day “Rosey,” a bolt of fabric, and a $100 sewing machine. You could have a custom suit ready the next day.

The same robot might then drive you to work, use your vehicle to run chores… or even earn money as an Uber driver.

From there, it’s easy to slip into speculation. What happens to clothing companies? Cleaning firms? Auto repair shops?

When robots can perform all the light manufacturing and services that humans can, it becomes blindingly obvious that the world of the future will look little like the world today.

It doesn’t take much imagination to realize that investors must act on this trend now.

And here is the best way to do it…

How to Join the Next AI Breakout

Two years ago, Eric teamed up with fellow InvestorPlace Senior Analysts – Louis Navellier and Luke Lango – to launch a special research project featuring only the best-of-the-best AI stocks.

And some have already taken off for big gains, including…

82% gains on Evolv Technologies Holdings Inc. (EVLV)…
285.6% gains on Nvidia Corp. (NVDA)…
80.3% gains on Oracle Corp. (ORCL)…
86.2% gains on Palantir Technologies Inc. (PLTR)…
And 74.8% gains on Vertiv Holdings Co. (VRT).

As they’ve recently noted at that research project, so many big advancements in robotics are now happening because AI processors are finally fast enough to re-create robots in a virtual space.

That allows researchers and AI models to test millions of possibilities digitally before a single action is taken.

In other words, these robots can try sewing millions of undershirts virtually before a single action is taken in real life.

Those advancements are now reaching a tipping point.

And so, Eric has joined Louis and Luke once more to create a new Day Zero Portfolio, focused entirely on the best investments in AI-powered robotics to keep you ahead of the curve.

It includes seven new AI recommendations set to capitalize on the growing world of robotics and Physical AI. These are a carefully selected group of companies that give you targeted exposure to the next wave of AI exponential progress.

And they just launched this new portfolio this week.

Click here to learn more about those companies – including one free pick – at their Day Zero Portfolio broadcast.

Our publisher will be taking this special free broadcast down at the end of this week… so I hope you’ll check it out now.

Until next week,

Thomas Yeung, CFA

Market Analyst, InvestorPlace

Manage your account
We hope this timely investment research is valuable to you. As you know the markets move fast and conditions change frequently. So please check the current issue for the most recent advice. Please note that we cannot be liable for any missed bulletins caused by overzealous filters. To ensure that you continue to receive this valuable part of your service please take a moment to add services@exct.investorplace.com to your address book.

You can reach us at feedback@investorplace.com or by calling 1-800-219-8592.

Too many emails?
Click or tap Manage my subscription to unsubscribe from free newsletter emails or Unsubscribe from marketing to stop receiving marketing emails.

InvestorPlace Media LLC
1125 N. Charles St,
Baltimore, MD 21201

Hamster fun and information

Investment Advisory Beats the S&P 500 by 288%

Investment Advisory Beats the S&P 500 by 288%

Dear Reader,

Why Financial Intelligence Report Works When Others Fail!

Since 2003, the Financial Intelligence Report (FIR) has helped everyday investors like you beat the market again and again.

Not by following the herd.

Not by chasing headlines.

But by listening to our brain trust of experts — elite investors, economists, and former policymakers — who see what’s coming next.

FIR’s brain trust helps you spot profit opportunities across:

Bull and bear markets
Inflation and deflation
Tech booms and demographic crashes
AI surges and rate cuts

You won’t just survive the next big shift — you’ll profit from it.

If you had put $100,000 into the S&P 500 back in 2021, you’d have around $144,000 today.

Not bad… but it’s nothing compared to this:

Subscribers to FIR saw that same $100,000 grow to over $475,000 — a +375.66% gain.

That’s not theory — it’s real performance.

And right now, you can get instant access to FIR — including all model portfolios, stock picks, and expert analysis.

Limited subscribership just opened, so CLICK HERE to learn more.

Don’t let this opportunity pass you by.

CLICK HERE NOW

Regards,

Newsmax Money

Hamster fun and information

Abbott Targets Top Dem; DHS Touts ‘Speedway Slammer’; Combs…

Breaking News from Newsmax.com

• Abbott Asks Court to Remove Texas House Dem Leader

Special: Is Cash Dead? The Genius Act Says Maybe

• Noem Announces ‘Speedway Slammer’ Detention Site

• Attorney for Combs: Pardon Broached With Trump

SPONSOR

ADVERTORIAL

The GENIUS Act Just Passed — Could Your Dollars Be Obsolete Soon?

While Americans were focused on the Israel-Arab conflicts and the ongoing war in Ukraine, Congress quietly passed one of the most transformative pieces of financial legislation in recent memory: the GENIUS Act.

Now signed into law by President Trump, this legislation may signal the end of physical cash and the start of a programmable digital dollar — a move experts warn could change the way you access, use, and even keep your money.

On the surface, it’s branded as “innovation.” A streamlined, efficient future where digital dollars flow through programmable wallets under federal oversight.

But underneath buzzwords lie a quiet revolution that could reshape the very meaning of money, ownership, and privacy. And when digital money comes, it doesn’t creep. It flips.

The GENIUS Act is a turning point in the digital economy moving us toward a cashless society and lays the legal foundation for:

Government-backed stablecoins (a digital form of the dollar)
Programmable money that can be tracked, blocked, taxed, or frozen instantly
Surveillance layers that monitor how, when, and where you spend
The slow elimination of cash — your anonymous, tangible lifeline

Imagine This: You wake up one day, to find out that you have been De-Banked. Your balance reads: $0.00

No fraud alert. No explanation. Just an error message that says:

“Access restricted. Contact administrator.”

Your money… isn’t yours anymore. It’s part of a system — and that system has conditions.

The Question Becomes:

How do you protect your savings in a world where control is digital and compliance is mandatory?

You opt out of the system — not illegally, but intelligently.

This is where physical gold and silver re-enter the national conversation — not as relics, but as lifeboats.

If your wealth is 100% digital, you are 100% exposed.

Because Gold is private by design it offers anonymity in an increasingly surveilled economy. It is Off-the grid and Tamper-proof. Immune to glitches, resets, or policy shifts. Gold and silver don’t require legislation to retain value. They simply are value.

The Bottom Line:

The passing of the GENIUS Act is a signal. A pivot point. The question now is NOT whether digital money is coming — but whether your portfolio is ready for it.

Download Your FREE Wealth Protection Guide

Allegiance Gold, LLC is not a broker-dealer and does not provide investment, tax, or legal advisory services. No statement in this communication should be construed as a recommendation to purchase or sell any security, or as investment, tax, or legal advice. Precious metals, like all investments, carry risk, are not suitable for all investors, and past performance does not guarantee future results. We do not guarantee any investment performance. Please consult your own investment, tax, or legal advisor prior to making any investment decision. Third-party information quoted or presented by us in this communication represents only the opinions of the third party and we do not endorse any third-party source of information. We are not affiliated with the U.S. Mint or any government agency. Â©Allegiance Gold, LLC 2025

*The free gold coin offer is available only while supplies last and is subject to change or withdrawal at any time. The coin shown in promotional materials is for illustrative purposes only; the actual coin received may vary in design, condition, and value. This offer is valid for qualified customers who open a Gold IRA through Allegiance Gold and meet all eligibility requirements. Additional terms and conditions may apply. Please contact us for full details.

Hamster fun and information

Fleeing Texas Dems on Hook for $400K; Trump Rips…

Breaking News from Newsmax.com

• Runaway Texas Democrats May Face $400K in Fines

Special: Drink Olive Oil for Fat Loss, Blood Sugar and Skin

• Trump: Schumer Extorting $2 Billion for Confirmations

• Dean Cain, Superman in ‘Lois & Clark,’ Joins ICE

SPONSOR

ADVERTORIAL

What would happen if you were to drink olive oil everyday?

Nurse Cat wondered the same… keep reading to find out her surprising results.

We all know that high-quality olive oil has massive health benefits. So I decided to do an experiment on myself and consume at least a couple of shots (2-4 Tablespoons) of high quality olive oil every day.

Here are some of the things I noticed:

Less hunger—Since olive oil is a healthy fat, consuming olive oil stops hunger pangs. But olive oil is a type of fat, and it seems it would cause weight gain. On the contrary, I lost a few poundsthe first two weeks of consuming olive oil. And when you look at the research, studies show that people who consumed at least 2T of olive oil a day lost more body fat than those eating similar calories and no olive oil.
Lower blood sugar—Along with less hunger, olive oil helps to lower blood sugar levels, helping to prevent type 2 diabetes and insulin resistance. When blood sugar and insulin are lower, you are less likely to be hungry or to store calories as fat. Olive oil also reduces ghrelin, a hormone that stimulates hunger.
Less aches, pains, and inflammation—Fresh EVOO contains a compound called oleocanthal which has an anti-inflammatory effect like ibuprofen—without the negative side effects. A study from Spain showed that men and women over the age of 55 who consumed olive oil for one month had decreased blood markers for inflammation, especially IFN-y and CXCL1.
Smoother skin—Olive oil is anti-inflammatory, and this is reflected in smoother skin, less sun damage, and reduction of any redness or irritation. The antioxidants in olive oil help prevent aging of the skin, as well as fighting skin cancer. The antibacterial component of olive oil also helps to fight acne and other skin infections. Olive oil applied directly to the skin also works great as an excellent moisturizer and wrinkle fighter.
Improved memory—My thinking was quicker, my focus improved, and my memory was sharper. Olive oil consumption has been shown to have positive effects on cognitive performance. Studies on olive oil consumption show slowed cognitive decline, and decreases in blood markers for Alzheimer’s disease, including amyloid beta proteins, tau, and p-tau.
Improved Cholesterol—While my cholesterol levels are very good, I noticed that total cholesterol numbers dropped, along with lower levels of LDL, and triglycerides—both of which are tied to heart disease. In addition, HDL (our good cholesterol) increased. In a meta-analysis of 27 different trials with olive oil, it was found that HDL increases significantly, while LDL and triglycerides are lowered. All good for heart health and longevity.
Better Digestion and Healthier Microbiome—Olive oil has a lot of gut health benefits. It nourishes beneficial bacteria and helps heal the gut lining. Research shows it relieves gut irritation including bloating and constipation. Certain healthy gut bacteria have positive effects on lowering cholesterol and fat loss, as well as increasing feelings of fullness.

Olive oil’s polyphenols can prevent other serious health issues. Olive oil is effective for its anti-inflammatory whole-body effects, its ability to fight and kill cancer cells, reverse fatty liver disease, protect the kidneys, and promote healthy brain and nerve function. Olive oil is effective for heart disease, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and to prevent or fight many cancers.

Olive oil is truly a powerful superfood and should be included in your diet on a regular basis. While I don’t know if I will continue to have a couple ‘shots’ of olive oil every day, I do know I will be adding generous amounts to my vegetables, salads, soups, and main dishes.

Be sure to look for “Extra Virgin, Cold Pressed” olive oil, and check the bottling date to see how fresh it is. Look for olive oil that comes in a dark tinted GLASS bottle. Avoid plastic or clear bottles. Higher quality olive oil full of polyphenols should have a rich, fruity taste and stings your throat when swallowed—this is a reflection of the amount and quality of the polyphenols it contains.

And speaking of high quality olive oil…

Heart Surgeon: If You Cook With Olive Oil You Should Know This

If you cook with or consume olive oil, it is very important that you read this carefully.

There is a common mistake that Americans make every time they purchase olive oil.

The truth is, most Americans have no idea where their olive oil comes from or the quality of their oil, so they have no clue what they are eating.

Some olive oil sold in stores could be old and spoiled. Fortunately, there are a few easy things you can look for to help avoid this.

=> Click here to learn the 3 things to look for when purchasing olive oil.

Cat Ebeling,
RN, MSN-PHN

P.S. If you cook with olive oil more than two times per week, and want to maximize the look of clear/smooth skin, and support joint health, it is even more important that you click here to find out more about your olive oil.

Hamster fun and information

Doctors Without Borders CEO exposed one ugly truth about…

Mark as Spam | Unsubscribe

Doctors Without Borders CEO exposed one ugly truth about Gaza aid that nobody saw coming

The humanitarian crisis in Gaza has reached a breaking point.

Aid organizations are supposed to be helping desperate civilians survive.

But the Doctors Without Borders CEO exposed one

…

[Read More…]

Nvidia could be TOAST while these 3 stocks surge…

Unsubscribe

Hey, Steve here:

I just found a stock that’s down 99% from its post-IPO highs…

Has been through a brutal reverse split…

And has become the poster child for how NOT to scale a space-tech company.

Most traders wouldn’t touch it with a ten-foot pole…

But sometimes, this is exactly where you find the most asymmetric opportunities.

I broke it all down in a recent blog…

Click here for the full scoop.

Nvidia and Palantir Could Be TOAST While 3 “Invisible Investments” Surge

We’ve all been told AI is a foundational breakthrough…

But what if everything you’ve heard in the mainstream media is a lie?

The reality is the huge “can’t miss” plays like Nvidia, AMD and Palantir could soon fold like a patio chair.

But just under the surface there’s a more practical revolution taking shape…

One that could mint over 10,000 “homegrown” millionaires.

Get the full details right here.

In Case You Missed It:

To your success,
Steve Place

New here? To quickly orient you…
We target stocks from a couple different vantage points.
First — by following a group of people I like to call “the best traders you’ve never heard of. Spoiler… they’re corporate insiders, and the same loophole that allows them to buy and sell their own stocks also allows us to follow their moves… often for explosive profits. Learn all about it right here.
We also leverage a little-known stock market “roadmap” to follow big institutional investors — the so-called smart money — and see the precise points where they are likely to buy and sell. I wrote a free guide to this strategy which you can read here — it also includes my No. 1 AI stock pick for 2025.

ABOUT US: At Global Profit Systems International LLC, we hold the conviction that financial literacy and freedom should be accessible to everyone, not just the seasoned investors. Our mission is to democratize the world of investing through comprehensive educational services and products. We simplify trading with our online platform, featuring an extensive collection of trading strategies designed to empower you at the start of your investment journey. We provide interactive webinars and training sessions because we are passionate about teaching. Regardless of the market opportunity, we foster a vibrant community of traders with shared interests, dedicated to dissecting daily market news together.
DISCLAIMER: FOR INFORMATION PURPOSES ONLY. The materials presented from Global Profit Systems International are for your informational purposes only. Neither Global Profit Systems International nor its employees offer investment, legal or tax advice of any kind, and the analysis displayed with various tools does not constitute investment, legal or tax advice and should not be interpreted as such. Using the data and analysis contained in the materials for reasons other than the informational purposes intended is at the user’s own risk.
DISCLAIMER: TRADE AT YOUR OWN RISK; TRADING INVOLVES RISK OF LOSS; SEEK PROFESSIONAL ADVICE. Global Profit Systems International is not responsible for any losses that may occur from transactions effected based upon information or analysis contained in the presented. To the extent that you make use of the concepts with the presentation material, you are solely responsible for the applicable trading or investment decision. Trading activity, including options transactions, can involve the risk of loss, so use caution when entering any option transaction. You trade at your own risk, and it is recommended you consult with a financial advisor for investment, legal or tax advice relating to options transactions. Please visit https://www.markettradersdaily.com/tos/ for our full Terms and Conditions.

Global Profit Systems International LLC
14422 Shoreside Way Suite 104-153,
Winter Garden 34787, FL.

Unsubscribe

Hamster fun and information

🚨 No One Caught What Elon Did After the…

Dear pahovis@aol.com

If you would like to unsubscribe, click here

Elon Musk rolled out his humanoid robot on stage…

It danced. It waved. It stole the spotlight.

But that wasn’t the real headline.

Because moments later, he made a far more powerful reveal.

A quiet announcement few covered… but those in-the-know say it could become his next trillion-dollar rocket.

The robot? Smoke and mirrors.

This? The real maneuver — and it’s already underway.

Before the mainstream media catches up… watch the footage nearly everyone overlooked.

Elon’s already acting on it.

Are you ready to follow?

See the real move behind the curtain »

All the best,
Simmy Adelman, Publisher
Behind the Markets

Top Minds Are Focused on These Trends (Ads)

1. Most Americans Missed Section 408(m) — Don’t Be One of Them

(from Allegiance Gold)

2. Not a gig. Not a hustle. Just your phone… paying you.

(from Mode Mobile)

3. Trump’s WW3 prophecy: The unthinkable may have occurred…

(from Goldco)

A note from the Editor: Successful Trading Sharks is dedicated to providing readers like you with unique opportunities. The message above from one of our business associates is one we believe you should take a serious look at.

You are receiving this email because you have expressed an interest in the Financial Education niche on one of our landing pages or sign-up forms.

Successful Trading Sharks is managed and possessed by Stark Media LLC.

For tailored assistance or any questions, please reply to this email for a speedy response.

For general queries, reach us at support@successfultradingsharks.com

222 Delaware St, Ste 2071 New Castle, DE 19720.

Privacy Policy | Terms & Conditions

UNSUBSCRIBE || Update Profile

Hamster fun and information

July’s ETF Massacre: The Shocking Truth Behind -13% Losses…

Forwarded this email? Subscribe here for more

July’s ETF Massacre: The Shocking Truth Behind -13% Losses That Wall Street Doesn’t Want You to Know

UnitedHealth’s $44 Collapse Triggers Healthcare ETF Bloodbath – Full Analysis Inside

ETF ALERT

AUG 6

READ IN APP

The Million-Dollar Question Every ETF Investor Asked in August: How did Healthcare and Copper ETFs—two of the market’s most reliable performers—suddenly become wealth-destroying machines that left even seasoned investors questioning their strategies? The answer reveals a perfect storm of policy chaos, earnings disasters, and global trade disruptions that transformed July 2025 into what many are calling “The Great ETF Reckoning.”

While the S&P 500 managed to hold its ground with modest gains, Healthcare ETFs like XLV hemorrhaged 4.6% and Copper ETFs such as CPER imploded by a devastating 13.1%, making them the undisputed champions of portfolio destruction. But here’s what Wall Street analysts won’t tell you: this wasn’t just a bad month—it was a fundamental shift that savvy investors are already using to position for massive profits in 2026.

July 2025 performance comparison showing Healthcare ETF (XLV) declining 4.6% while Copper ETF (CPER) plummeted 13.1%

Healthcare ETFs: When “Defensive” Stocks Become Offensive to Your Portfolio

The $960 Billion Policy Bomb That Detonated in July

What happened in the first week of July will reshape healthcare investing forever. President Trump’s signing of the “One Big Beautiful Bill Act” on Independence Day wasn’t just legislative theater—it was a financial earthquake that triggered the biggest healthcare sector selloff since the Affordable Care Act debates. The legislation’s $960 billion in Medicaid cuts over the next decade didn’t just trim around the edges; it fundamentally rewrote the economics of America’s healthcare system.

The numbers are staggering and the implications terrifying for traditional healthcare investors:

Medicaid work requirements affecting 10-17 million Americans
Provider payment caps locked at Medicare rates (typically 60-80% of commercial rates)
Co-pays for non-primary care services jumping to $35
State flexibility to impose asset limits and drug testing requirements

Healthcare ETFs didn’t just decline—they collapsed under the weight of investor panic. The Health Care Select Sector SPDR Fund (XLV) suffered its worst single-day massacre of 2.8% on July 31st, while specialized healthcare ETFs like IHF (Healthcare Providers) and ARKG (Genomics) got absolutely decimated with losses of 10.5% and 10.9% respectively.

The UnitedHealth Earnings Apocalypse That Broke Healthcare Bulls

July 29th, 2025: The day healthcare investing died. UnitedHealth Group’s second-quarter earnings report wasn’t just disappointing—it was a complete destruction of everything analysts thought they knew about healthcare profitability. When the nation’s largest health insurer, representing over 12% of XLV’s holdings, delivered adjusted earnings of $4.08 versus the expected $4.48, it was like watching a financial house of cards collapse in real-time.

But the real shocker came with the guidance revision that sent shockwaves through every healthcare portfolio:

Full-year 2025 EPS guidance slashed from $30 to just $16 (a mind-blowing 47% reduction)
Medical care ratio exploding to 89.4% (up 430 basis points year-over-year)
Year-to-date stock decline reaching a brutal 44%

The company’s medical expenses were literally consuming nearly 90 cents of every premium dollar—a ratio that makes profitable growth virtually impossible without massive premium increases or service cuts. Combined with ongoing Department of Justice investigations into billing practices, UnitedHealth became the poster child for everything wrong with healthcare investing.

The Clinical Trial Failure Cascade That Crushed Biotech Dreams

July 2025 will go down as the month biotech innovation died a thousand deaths. The cascade of clinical trial failures read like a horror story for anyone betting on medical breakthroughs. Sarepta Therapeutics faced FDA investigations after a third patient death linked to its gene therapy programs, while the FDA’s decision to halt clinical trials involving American cell exports to foreign laboratories sent shockwaves through the entire biotech ecosystem.

The carnage included household names and promising startups alike:

AbbVie’s $8.7 billion Cerevel acquisition looking like a disaster as emraclidine failed in schizophrenia trials
Eli Lilly’s anti-tau Alzheimer’s drug missing its primary endpoint
AstraZeneca’s TROP2 antibody-drug conjugate bombing in breast cancer studies
Merck announcing 6,000 job cuts amid $3 billion in cost reductions

The biotech sector didn’t just face setbacks—it confronted an existential crisis that questioned whether the traditional drug development model could survive in an era of heightened regulatory scrutiny and policy hostility.

Copper ETFs: When “Dr. Copper” Flatlined and Called Time of Death on Global Growth

The Tariff Reversal That Triggered Commodity Chaos

July 30th, 2025: The day President Trump accidentally crashed the copper market with a single exemption. What started as a supply shortage panic became a spectacular unwinding when Trump’s surprise decision to exempt refined copper forms from his 50% tariff threat sent the United States Copper Index Fund (CPER) into a death spiral, losing 13.1% for the month.

Here’s how the copper market went from hero to zero in 30 days:

July opened with copper prices near all-time highs of $5.94/lb as traders front-loaded imports
The tariff exemption for ore, concentrates, and cathodes (but not semi-finished products) created instant chaos
U.S. copper premium to London Metal Exchange collapsed from a record 30% to negligible levels
CPER experienced its worst single day on July 31st, plummeting 12.8% as speculative positions unwound

The iPath Series B Bloomberg Copper Subindex Total Return ETN (JJC) suffered similar devastation, declining approximately 12% as futures curves normalized and the tariff-driven supply distortions that had artificially supported prices evaporated.

Manufacturing PMI: The Economic Indicator That Exposed Global Weakness

When the S&P Global U.S. Manufacturing PMI fell to 49.5 in July from June’s 37-month high of 52.9, it wasn’t just a data point—it was a death knell for copper demand. The first contraction in factory activity since December revealed the fundamental weakness hiding beneath copper’s tariff-driven price surge.

The global manufacturing picture painted an even grimmer reality:

China’s manufacturing PMI dropped to 49.5 from 50.4, with export orders contracting for the fourth straight month
Despite China’s refined copper production hitting record highs, growth was driven by inventory depletion rather than robust demand
Processing fees for copper concentrate began recovering from record lows, signaling oversupply conditions

The Dollar’s Revenge: How Currency Dynamics Crushed Commodity Dreams

After experiencing its worst first half since 1973 with an 11% decline, the U.S. dollar’s July stabilization created a perfect storm for commodity investors. Currency dynamics, combined with shifting Federal Reserve expectations and persistent inflation above the 2% target, created headwinds that copper ETFs simply couldn’t overcome.

J.P. Morgan’s commodity research team delivered the brutal reality check that many investors didn’t want to hear: LME copper prices projected to slide toward $9,100 per metric ton in Q3 2025, reflecting the “hangover” from inventory front-loading and volatile Chinese demand patterns.

Healthcare and Copper ETFs dominated July 2025’s worst performers, with copper ETFs declining over 12% and healthcare ETFs ranging from -2.8% to -11%

What The Smart Money Already Knows: Expert Forecasts & The Contrarian Opportunity

The Short-Term Outlook: Why Pain Could Continue Through Q4 2025

Healthcare Sector Roadmap to Recovery (Or Further Destruction):

September 29th Drug Pricing Deadline: Trump’s executive order requiring 17 drug companies to slash prices could trigger another sector-wide selloff
Q3 Earnings Bloodbath: UnitedHealth’s guidance reset may prompt copycat cuts across the sector, potentially creating oversold conditions for contrarian investors
Medicaid Implementation Timeline: State-level work requirement rollouts will determine coverage losses, creating winners and losers based on geographic exposure

The sector’s forward P/E multiple has compressed to 15.9x—an 11% discount to historical averages and 20% discount to global equities, representing the largest valuation gap in 16 years. While this screams “value,” it reflects legitimate structural challenges rather than temporary market inefficiency.

Copper Market Crystal Ball:

Chinese Manufacturing PMI: Monthly readings above 50 would signal demand recovery, but current trends suggest continued weakness
Federal Reserve Policy Pivot: Accelerated rate cuts could weaken the dollar and provide commodity tailwinds
Tariff Policy Evolution: Further changes to copper classifications could create new volatility waves

The unwinding of tariff-driven inventory builds is expected to persist through Q4 2025, with Chinese refined copper imports potentially declining 8% as domestic production meets more local demand.

The Long-Term Thesis: Why These Crashes Might Be Setting Up 2026’s Biggest Winners

Healthcare’s Demographic Destiny:
Despite current policy headwinds, the fundamental aging population trend remains unstoppable. Healthcare demand is literally written in demographic stone, with baby boomers creating persistent growth drivers that no legislation can eliminate. The key question isn’t whether healthcare will grow—it’s which companies will adapt fastest to the new regulatory reality.

The Copper Electrification Supercycle:
Benchmark Mineral Intelligence’s forecast that copper demand for electric vehicles alone will jump to 2.2 million tons by 2030 (versus 1.2 million in 2025) represents a structural demand shift that transcends cyclical volatility. Power grid expansion for renewable energy integration creates another massive demand driver that could absorb years of supply growth.

How to Turn July’s Disaster Into Your Portfolio’s Next Goldmine

For Tactical Investors: The Contrarian Playbook

Healthcare ETF Opportunities:

Entry Strategy: Consider dollar-cost averaging into XLV below $130 with 6-12 month time horizon
Risk Management: Position size should account for continued policy uncertainty through 2026 elections
Catalyst Monitoring: Track Medicare Advantage bid submissions and state Medicaid waiver applications

Copper ETF Speculation:

Volatility Play: CPER’s extreme volatility creates swing trading opportunities for risk-tolerant investors
Infrastructure Themes: Focus on copper exposure tied to U.S. infrastructure spending and grid modernization
China Dependency Risk: Monitor manufacturing PMI data and trade policy developments closely

For Strategic Investors: The Patient Capital Advantage

Healthcare Value Harvesting:
Current valuations represent potential decade-making entry points for investors willing to navigate 2-3 years of policy uncertainty. Focus on companies with:

Strong cash flow generation capabilities
Diversified geographic exposure beyond U.S. markets
Innovation pipelines in areas less susceptible to price controls

Commodity Cycle Positioning:
Copper’s cyclical nature means current weakness could set up the next upcycle. Consider:

Physical copper exposure through ETFs for 3-5 year holding periods
Mining company equity exposure for leveraged commodity play
Infrastructure-linked copper demand themes (renewable energy, EVs, data centers)

Why July’s Bloodbath Might Be 2026’s Setup of the Decade

July 2025 taught us that even “defensive” sectors can become offensive to your portfolio when policy and fundamentals collide. Healthcare and Copper ETFs didn’t just underperform—they revealed the fragility of investment themes that seemed bulletproof just months earlier.

But here’s the contrarian insight that could define the next market cycle: The same forces that created July’s massacre are also creating the conditions for spectacular recoveries. Healthcare’s demographic tailwinds haven’t disappeared—they’ve been temporarily obscured by political noise. Copper’s electrification thesis remains intact—it’s just been delayed by cyclical headwinds and trade policy chaos.

The investors who recognize this distinction—between temporary disruption and permanent destruction—will be the ones positioning for 2026’s biggest winners while others are still licking their July wounds.

Never Miss Another Market-Moving Alert: Subscribe to ETF Alert for daily insights that help you stay ahead of market chaos and spot opportunities before Wall Street catches on. Because in investing, being early isn’t just an advantage—it’s everything.

ETF Alert is free today. But if you enjoyed this post, you can tell ETF Alert that their writing is valuable by pledging a future subscription. You won’t be charged unless they enable payments.

Pledge your support

COMMENT

RESTACK

Category: Hamster fun and information

Stop Overlooking Qualcomm—Here’s What the Market’s Missing

Key Points

Why the Market’s Reaction Looks Off

What the Chart Is Signaling Now

The Analysts Remain Bullish

Share this:

Like this:

Why Bloom Energy Stock Could Break to New Highs

Key Points

Giving Short Sellers a Run for Their Money

Bullishness Spreads for Bloom Energy Stock

Share this:

Like this:

Robots Are the Next Big AI Play – These Stocks Are Set to Soar

The Fabric of the Robotics Revolution

How to Join the Next AI Breakout

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

Share this:

Like this:

UnitedHealth’s $44 Collapse Triggers Healthcare ETF Bloodbath – Full Analysis Inside

Healthcare ETFs: When “Defensive” Stocks Become Offensive to Your Portfolio

The $960 Billion Policy Bomb That Detonated in July

The UnitedHealth Earnings Apocalypse That Broke Healthcare Bulls

The Clinical Trial Failure Cascade That Crushed Biotech Dreams

Copper ETFs: When “Dr. Copper” Flatlined and Called Time of Death on Global Growth

The Tariff Reversal That Triggered Commodity Chaos

Manufacturing PMI: The Economic Indicator That Exposed Global Weakness

The Dollar’s Revenge: How Currency Dynamics Crushed Commodity Dreams

What The Smart Money Already Knows: Expert Forecasts & The Contrarian Opportunity

The Short-Term Outlook: Why Pain Could Continue Through Q4 2025

The Long-Term Thesis: Why These Crashes Might Be Setting Up 2026’s Biggest Winners

How to Turn July’s Disaster Into Your Portfolio’s Next Goldmine

For Tactical Investors: The Contrarian Playbook

For Strategic Investors: The Patient Capital Advantage

Why July’s Bloodbath Might Be 2026’s Setup of the Decade

Share this:

Like this: